Fingerprint Spectrum Detection Method of Wushen Decoction

The fingerprint map of Wushen Decoction was established through high-performance liquid chromatography, which solved the problem of single quality control of Chinese medicine compound preparations, achieved comprehensive testing and evaluation of the quality of Wushen Decoction, and ensured the safety of medication.

CN116008456BActive Publication Date: 2024-12-03JIANGSU OCEAN UNIV
View PDF 5 Cites 0 Cited by

Patent Information

Application Number
CN202310069052.3
Authority / Receiving Office
CN · China
Patent Type
Patents(China)
Current Assignee / Owner
Filing Date
2023-02-06
Publication Date
2024-12-03
Estimated Expiration
2043-02-06

AI Technical Summary

Technical Problem

The prior art Chinese medicine compound preparations basically have only one or two index ingredients in content control, and the quality control is single, making it difficult to fully reflect the quality status of Wushen Tang compositions with many medicinal flavors, many components and many targets.

Method used

The fingerprint of Wushen Decoction was established by high-performance liquid chromatography. Acetonitrile and 0.1% phosphoric acid aqueous solution were used as mobile phases. Aglient Eclipse XDB-C18 chromatography column was used, and the column temperature was 30℃, and the detection wavelength was 254nm. The gradient elution procedure was used. The best chromatographic analysis conditions were selected to generate the fingerprint map of Wushen Tang, and quality control was carried out through the fingerprint map similarity evaluation system.

Benefits of technology

It has achieved comprehensive, objective and accurate detection and evaluation of the quality of Wushen Decoction, ensured the safety of patients' medication, and provided a scientific basis for quality control of Wushen Decoction.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure CN116008456B_ABST
    Figure CN116008456B_ABST
Patent Text Reader

Abstract

The present invention discloses a method for determining the fingerprint of Wushen Decoction. The method comprises: step 1: preparation of a test solution of Wushen Decoction; step 2: preparation of a mixed standard; step 3: respectively accurately aspirating the test solution and the mixed reference solution and injecting them into a high performance liquid chromatograph, and recording the chromatogram; step 4: exporting the data file of the fingerprint of Wushen Decoction obtained in step 3 from the instrument, and importing it into a similarity evaluation system for Chinese medicine chromatographic fingerprints, selecting the chromatographic peaks existing in the chromatograms of different batches of Wushen Decoction as common peaks; generating a control fingerprint of Wushen Decoction by using an average value calculation method; and calculating the relative retention time and relative peak area of ​​each common peak. The fingerprint detection method of Wushen Decoction provided by the present invention has good stability, high precision, and good reproducibility, and can comprehensively and objectively characterize the quality of Wushen Decoction.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] The invention belongs to the technical field of traditional Chinese medicine detection, and particularly relates to a fingerprint spectrum detection method for Wushen Decoction. Background Art

[0002] Wushen Decoction was first mentioned in "Dongtian Aozhi·Volume 7·Bone Carbuncle" (1694 AD) by Chen Shiduo of the Qing Dynasty. The prescription consists of five medicinal materials: honeysuckle, Viola yedoensis, Achyranthes bidentata, Poria cocos and Plantago seed. At present, Wushen Decoction is mainly used in the treatment of chronic osteomyelitis in clinical practice. Honeysuckle is the main medicine, Viola yedoensis is supplemented, Poria cocos and Plantago seed are adjuvants, and Achyranthes bidentata is the guiding medicine. Wushen Decoction can remove dampness and detoxify. Honeysuckle and Viola yedoensis can clear away heat and detoxify, cool blood and reduce swelling; Poria cocos and Plantago seed can promote diuresis and relieve stranguria, penetrate dampness and quench thirst; Achyranthes bidentata can promote blood circulation and remove blood stasis, and guide blood downward. The combination of the five medicines can both remove toxins and remove dampness. At present, there are few studies on Wushen Decoction, and most of them are in clinical application, but there is no in-depth analysis of the impact of differences in internal active ingredients on the quality of Wushen Decoction.

[0003] Therefore, it is necessary to establish the HPLC fingerprint characteristic map of Wushen Decoction based on the existing instrumental analysis technology, analyze it through the Chinese medicine chromatographic characteristic map similarity evaluation system, and establish a control fingerprint map to provide a basis for the quality control of Wushen Decoction, which is of great significance. Summary of the invention

[0004] The technical problem to be solved by the present invention is to overcome the defects that the Chinese herbal compound preparations in the prior art basically have only one or two indicator components in content control, single quality control, few indicators, and it is difficult to fully reflect the quality status of the Wushen Decoction composition with multiple medicinal flavors, multiple components and multiple targets, thereby providing a method for establishing a fingerprint map of Wushen Decoction and a fingerprint map.

[0005] The present invention provides the following technical scheme: a method for establishing the fingerprint of Wushen Decoction, using high performance liquid chromatography, using an octadecylsilane bonded silica gel chromatographic column, using acetonitrile as mobile phase A, and an aqueous solution of 0.1% phosphoric acid as mobile phase B, with a flow rate of 1.0 mL / min, a column temperature of 30°C, an injection volume of 10 μL, and a detection wavelength of 254 nm, and performing gradient elution according to the following table

[0006]

[0007] In some embodiments, the chromatographic column is Aglient Eclipse XDB-C18, with specifications of 4.6×150 mm and 5 μm.

[0008] In some embodiments, the method for establishing the fingerprint of Wushen Decoction comprises the following steps:

[0009] Preparation of test solution: Weigh the Wushen Decoction powder accurately, place it in a stoppered conical flask, add methanol to extract, cool the extract to room temperature and weigh it again, and make up the missing weight with methanol solution. Centrifuge, filter the supernatant with a filter membrane, and take the filtrate to obtain the Wushen Decoction test solution;

[0010] Preparation of mixed reference solution: Accurately weigh aesculin, aesculetin, luteolin, β-ecdysterone, geniposide, caffeic acid, chlorogenic acid, and verbascoside reference substances, place in a volumetric flask, add methanol to dissolve and shake to volume, filter with a microporous filter membrane to obtain a mixed reference solution.

[0011] In some embodiments, the method for establishing the fingerprint of Wushen Decoction comprises the following steps:

[0012] Preparation of test solution: Accurately weigh 4.65g of honeysuckle, 1.55g of Viola yedoensis, 0.725g of Achyranthes bidentata, 1.55g of Plantago seed, and 1.55g of Poria, grind them into powder and mix them evenly, accurately weigh 1g, place it in a stoppered conical flask, add 10mL of 50% methanol by volume, extract by ultrasonic for 40min, take out, take the filtrate, filter it with a 0.22μm microporous filter membrane to obtain the Wushen Decoction test solution.

[0013] Preparation of mixed reference solution: Accurately weigh 10.39 mg of aesculin A reference, 10.56 mg of aesculin E reference, 9.28 mg of luteolin reference, 14.48 mg of β-ecdysterone reference, 8.90 mg of geniposide reference, 11.34 mg of caffeic acid reference, 10.63 mg of chlorogenic acid reference and 9.54 mg of verbascoside reference, and place in a 25 mL volumetric flask. Add 50% methanol to dissolve and shake to volume, filter with a 0.22 μm microporous filter membrane to obtain mixed reference solutions of aesculin, aesculetin, luteolin, b-ecdysterone, geniposide, caffeic acid, chlorogenic acid, and verbascoside with concentrations of 415.60, 422.40, 371.20, 579.20, 356.00, 453.60, 425.20, and 381.60 mg / mL, respectively.

[0014] Chromatographic conditions: The chromatographic column is Aglient Eclipse XDB-C18, with specifications of 4.6×150mm, 5μm; acetonitrile is used as mobile phase A, and 0.1% phosphoric acid aqueous solution is used as mobile phase B; the flow rate is 1.0mL / min; the column temperature is 30℃; the injection volume is 10μL; the detection wavelength is 254nm; the gradient elution is performed as shown in the table below;

[0015]

[0016] Determination: Accurately pipette 10 μL of the test solution and inject it into the high performance liquid chromatograph, and determine it according to the high performance liquid chromatography method to obtain the fingerprint of Wushen Decoction.

[0017] The fingerprint spectrum described in the above method includes 10 common peaks, and the retention time of each peak is as follows: Figure 2 shown.

[0018] The Wushen Soup fingerprint detection method is applied to the quality control of Wushen Soup, with the fingerprint similarity being greater than 0.90 as the inspection quality control standard.

[0019] Beneficial effects of the invention: According to the structural properties of the active ingredients contained in Wushen Decoction, including glycosides, flavonoids, steroids, organic acids, alkaloids, etc., the invention screens out the best chromatographic analysis conditions such as mobile phase composition, gradient elution program, detection wavelength, chromatographic column, column temperature, etc. through experiments. It has been verified by multiple experiments that the Wushen Decoction fingerprint spectrum detection method provided by the invention can comprehensively, objectively and accurately detect and evaluate the quality of Wushen Decoction, which is of great significance for ensuring the safety and effectiveness of patients' medication. BRIEF DESCRIPTION OF THE DRAWINGS

[0020] Figure 1 This is the chromatogram of the mixed reference solution of Wushen Decoction;

[0021] Figure 2 These are the fingerprints of 10 batches of Wushen Soup samples. DETAILED DESCRIPTION

[0022] The present invention is further explained below in conjunction with specific examples. It should be understood that these examples are only used to illustrate the present invention and are not used to limit the scope of the present invention. After reading the present invention, various equivalent modifications of the present invention by those skilled in the art all fall within the scope defined by the claims attached to this application.

[0023] Example 1 Establishment and application of Wushen Decoction comparative fingerprint

[0024] 1. Instruments, reagents and medicinal materials

[0025] Shimadzu LC-20AD high performance liquid chromatograph (Shimadzu Corporation, Japan); XS205DU 1 / 100,000 electronic analytical balance (Mettler-Toledo, Switzerland); KQ2200DE numerically controlled ultrasonic cleaner (Kunshan Ultrasonic Instrument Co., Ltd.); DFY-200A high-speed universal pulverizer (Shanghai Bilang Instrument Co., Ltd.); Avanti J-26SXP high-speed refrigerated centrifuge (Beckman Coulter Trading (China) Co., Ltd., USA);

[0026] Methanol and acetonitrile (chromatographic grade, Sigma-Aldrich (Shanghai) Trading Co., Ltd.); phosphoric acid, mass fraction 85%, Sinopharm Chemical Reagent Co., Ltd.; other reagents were of analytical grade.

[0027] The five medicinal materials for Wushen Decoction were collected from all over the country, with 10 batches of each medicinal material. Their origins and batches are shown in Tables 1 and 2.

[0028] Table 1

[0029]

[0030]

[0031] Table 2

[0032]

[0033] The optimal screening process of the Wushen Decoction fingerprint detection method:

[0034] 1. Investigation of sample extraction conditions

[0035] (1) The present invention investigates the extraction effects of water, ethanol and methanol as extraction solvents. The results show that the peak information of the spectrum obtained by extraction with 50% methanol by volume is the richest, so 50% methanol by volume is selected as the extraction solvent.

[0036] (2) The present invention compares the ultrasonic extraction and reflux extraction methods, and the results show that the response value of the fingerprint chromatographic peak obtained by ultrasonic extraction is larger, the separation is better, and it can be basically completely extracted within 40 minutes. Therefore, ultrasonic 40-minute extraction is selected as the extraction method for Wushen Decoction samples.

[0037] 2. Selection of mobile phase

[0038] The present invention investigates the elution effect of each substance in Wushen Decoction using methanol-water, acetonitrile-water, methanol-0.1% phosphoric acid solution, methanol-0.4% phosphoric acid solution, acetonitrile-0.1% phosphoric acid solution, and acetonitrile-0.4% phosphoric acid solution as mobile phases. It was found that when methanol was used as the organic phase, the baseline drift was serious, the peaks were less and the peak shape was not good. In contrast, the acetonitrile-water system as the mobile phase could obtain a better separation effect, with a stable baseline, a large number of peaks and a good peak shape. Then, different proportions of phosphoric acid water were investigated, and it was found that the separation effects of 0.1% phosphoric acid water and 0.4% phosphoric acid water were almost the same, so the mobile phase was finally determined to be acetonitrile-0.1% phosphoric acid solution.

[0039] After determining the composition of the mobile phase, the present invention conducted experimental screening of the elution program. Due to the structural characteristics of the active ingredients contained in Wushen Decoction, including glycosides, flavonoids, steroids, organic acids, alkaloids, etc., the separation degree of isocratic elution is general. Through a large number of experimental screenings, it was found that the separation degree of different gradient elution programs was quite different. Finally, a gradient elution method capable of separating 19 common peaks was obtained, namely:

[0040]

[0041] 3. Selection of detection wavelength

[0042] The peak conditions at 203nm, 254nm and 330nm were investigated. The results showed that the chromatographic peak information obtained at 254nm was more complete, the response value was higher and the peak area was larger, which was representative. Therefore, 254nm was determined as the detection wavelength of the Wushen Decoction fingerprint spectrum.

[0043] 4. Selection of column temperature

[0044] The effects of column temperatures of 25°C, 30°C and 35°C on the separation of Wushen Decoction samples were investigated respectively. The results showed that when the column temperature was 30°C, the retention time of each substance was moderate, the separation was good, and the column pressure was low. Therefore, 35°C was selected as the optimal column temperature condition.

[0045] 2. A fingerprint detection method for Wushen Decoction, comprising the following steps:

[0046] (1) Preparation of test solution

[0047] The medicinal material powders of the same batch of Wushen Decoction in Tables 1 and 2 above (4.65 g of honeysuckle, 1.55 g of Viola yedoensis, 0.725 g of Achyranthes bidentata, 1.55 g of Plantago, and 1.55 g of Poria) were mixed evenly (such as J1-C1-F1-Z1-N1, J2-C2-F2-Z2-N2...), and 1 g of each of the 10 batches of Wushen Decoction sample powders was accurately weighed and placed in stoppered conical flasks respectively. 10 mL of 50% methanol by volume was added, and ultrasonic extraction was performed for 40 min. The filtrate was taken out and filtered through a 0.22 μm microporous filter membrane to obtain 10 batches of Wushen Decoction test solutions.

[0048] (2) Preparation of mixed reference solution

[0049] Accurately weigh 10.39 mg of aesculin A reference substance, 10.56 mg of aesculin B reference substance, 9.28 mg of luteolin reference substance, 14.48 mg of b-ecdysterone reference substance, 8.90 mg of geniposide reference substance, 11.34 mg of caffeic acid reference substance, 10.63 mg of chlorogenic acid reference substance and 9.54 mg of verbascoside reference substance, place them in a 25 mL volumetric flask, and add 50% methanol Dissolve and shake to volume, filter with a 0.22 μm microporous filter membrane to obtain mixed reference solutions of aesculin, aesculetin, luteolin, b-ecdysterone, geniposide, caffeic acid, chlorogenic acid, and verbascoside with concentrations of 415.60, 422.40, 371.20, 579.20, 356.00, 453.60, 425.20, and 381.60 mg / mL, respectively.

[0050] (3) Determination of the fingerprint of Wushen Decoction by HPLC

[0051] Ten batches of Wushen Decoction sample solutions prepared according to method (1) and the mixed reference solution prepared in step (2) were respectively injected into a high performance liquid chromatograph.

[0052] Chromatographic conditions were as follows: Aglient Eclipse XDB-C 18 column, 4.6×150 mm, 5 μm; mobile phase: acetonitrile in phase A, 0.1% phosphoric acid in phase B, gradient elution, volume flow rate: 1.0 mL / min, column temperature: 30°C, injection volume: 10 μL, detection wavelength: 254 nm; gradient elution program:

[0053]

[0054] The fingerprint of the reference substance is as follows Figure 1 As shown in (where geniposide is peak 1, retention time is 6.366min, aesculin is peak 2, retention time is 9.633min, chlorogenic acid is peak 3, retention time is 12.084min, aesculin is peak 4, retention time is 12.715min, caffeic acid is peak 5, retention time is 13.398min, luteolin is peak 6, retention time is 26.477min, b-ecdysterone is peak 7, retention time is 27.597min, and verbascoside is peak 8, retention time is 29.196min). In addition, the fingerprint of the test sample is as follows Figure 2 shown.

[0055] (4) The fingerprints of the 10 batches of Wushen Decoction test solutions obtained in step 3 were exported and imported into the Chinese Medicine Chromatographic Fingerprint Similarity Evaluation System 2009A; the chromatographic peaks existing in the chromatograms of the 10 batches of Wushen Decoction were selected as common peaks; the control fingerprint of Wushen Decoction was generated by the average value calculation method, and the relative retention time and relative peak area of ​​each common peak were calculated. There were 19 common fingerprint peaks in the control fingerprint (the fingerprint similarity of the 10 batches of test solutions was greater than 0.90).

[0056] Example 2 Methodological Investigation

[0057] 1. Precision test

[0058] The same batch of Wushen Decoction sample powder (S1) was taken, and the test solution was prepared according to the method of step (1) of the above embodiment 1. The injection was repeated 6 times according to the chromatographic conditions of step (3) of the above embodiment 1. Peak 7 was used as the reference peak, and the relative retention time and relative peak area of ​​each common peak were calculated. The RSDs were all <2.98%, indicating good precision.

[0059] 2. Repeatability test

[0060] Take Wushen Decoction sample powder (S1), prepare 6 test solutions in parallel according to the method of step (1) of the above embodiment 1, inject 6 times according to the chromatographic conditions of step (3) of the above embodiment 1, take peak 7 as the reference peak, and calculate the relative retention time and relative peak area RSD values ​​of each common peak, which are all <3.0%, proving that the method has good repeatability.

[0061] 3. Stability test

[0062] Take Wushen Decoction sample powder (S1), prepare a test solution according to the method of step (1) of the above embodiment 1, and analyze the sample at 0h, 2h, 4h, 8h, 12h and 24h after sample preparation according to the chromatographic conditions of step (3) of the above embodiment 1, and use peak 7 as the reference peak to calculate the relative retention time and relative peak area of ​​each common peak. The RSD values ​​are all <3.0%, which proves that the test solution has good stability within 24h.

[0063] The present invention uses fingerprint technology to establish the HPLC fingerprint of Wushen Decoction, which can quickly and intuitively identify the pharmacodynamic material basis in complex Chinese medicine decoction systems; at the same time, combined with chemical recognition modes such as cluster analysis (HCA) and partial least squares-discriminant analysis (PLS-DA), the quality differences between batches of samples are evaluated, providing a reference for the study of key quality attributes of Wushen Decoction, and providing a useful reference for the preparation process, quality control, and product safety and stability evaluation of subsequent related preparations.

[0064] The above embodiments are only exemplary embodiments of the present invention and are not intended to limit the present invention. The protection scope of the present invention is defined by the claims. Those skilled in the art may make various modifications or equivalent substitutions to the present invention within the essence and protection scope of the present invention, and such modifications or equivalent substitutions shall also be deemed to fall within the protection scope of the present invention.

Claims

1. A method for determining the fingerprint of Wushen Decoction, characterized in that: The following steps are involved: Preparation of test solution: accurately weigh 4.65g of honeysuckle, 1.55g of Viola yedoensis, 0.725g of Achyranthes bidentata, 1.55g of Plantago seed and 1.55g of Poria cocos, grind them into powder and mix them evenly, accurately weigh 1g, put it into a stoppered conical flask, add 10mL of 50% methanol by volume, extract by ultrasonic for 40min, take out, take the filtrate, filter it with a 0.22μm microporous membrane, and obtain the Wushen Decoction test solution; Preparation of mixed reference solution: Accurately weigh 10.39 mg of aesculin A reference, 10.56 mg of aesculin E reference, 9.28 mg of luteolin reference, 14.48 mg of β-ecdysterone reference, 8.90 mg of geniposide reference, 11.34 mg of caffeic acid reference, 10.63 mg of chlorogenic acid reference and 9.54 mg of verbascoside reference, and place in a 25 mL volumetric flask. Add 50% methanol to dissolve and shake to volume, filter with a 0.22 μm microporous filter membrane to obtain mixed reference solutions of aesculin, aesculetin, luteolin, b-ecdysterone, geniposide, caffeic acid, chlorogenic acid and verbascoside with concentrations of 415.60, 422.40, 371.20, 579.20, 356.00, 453.60, 425.20 and 381.60 mg / mL, respectively; Chromatographic conditions: The chromatographic column is Aglient Eclipse XDB-C18, with specifications of 4.6×150mm, 5μm; acetonitrile is used as mobile phase A, and 0.1% phosphoric acid aqueous solution is used as mobile phase B; the flow rate is 1.0mL / min; the column temperature is 30℃; the injection volume is 10μL; the detection wavelength is 254nm; the gradient elution is performed as shown in the table below; Determination: Accurately pipette 10 μL of the test solution and inject it into the high performance liquid chromatograph, and determine it according to the high performance liquid chromatography method to obtain the fingerprint of Wushen Decoction.

2. Application of the method for determining the fingerprint of Wushen Soup as described in claim 1 in the quality control of Wushen Soup, with the fingerprint similarity being greater than 0.90 as the inspection quality control standard.

Citation Information

Patent Citations

  • Medicine for treating gouty arthritis by combining oral administration and external application of traditional Chinese medicines

    CN105641564A

  • Traditional Chinese medicine for treating damp-heat stagnation syndrome type inguinal carbuncle disease

    CN105998906A

  • Detection method for medicated leaven fingerprint spectrum

    CN108982696A

  • Method for detecting fingerprint spectrum of Guigui zhugan decoction

    CN109709251A

  • Novel ironing moxibustion apparatus combining moxibustion and ironing methods and manufacturing method therefor

    WO2018086501A1